Table 1.
Categories of consumption (cups/unit of time) |
|||||
---|---|---|---|---|---|
Tea | ≤1/week | 2-6/week | 1/day | ≥2/day | |
|
|||||
Controls, No. | 594 | 109 | 69 | 91 | |
Mean age, y (SD) | 61.2 (8.4) | 59.3 (7.1) | 63.8 (6.9) | 63.5 (7.3) | |
Caucasian, % | 90.7 | 85.3 | 92.8 | 92.3 | |
First-degree family history of prostate cancer, % | 12.3 | 11.9 | 7.2 | 9.9 | |
College or graduate degree, % | 56.4 | 62.4 | 65.2 | 65.9 | |
Mean BMI, kg/m2 (SD) | 27.9 (4.6) | 27.5 (4.1) | 26.5 (4.8) | 27.1 (4.8) | |
Never smoker, % | 44.8 | 40.4 | 56.5 | 57.1 | |
Aspirin use*, % | 51.3 | 53.2 | 53.6 | 53.8 | |
Non-aspirin NSAID use*, % | 20.9 | 23.9 | 13.0 | 16.5 | |
Diabetes mellitus, % | 10.4 | 11.9 | 10.1 | 9.9 | |
History of PSA testing†, % | 58.2 | 52.3 | 60.9 | 71.4 | |
≥2 cups of coffee per day, % | 46.5 | 35.5 | 32.4 | 24.2 | |
|
|||||
Coffee | ≤1/week | 2-6/week | 1/day | 2-3/day | ≥4/day |
|
|||||
Controls, No. | 257 | 100 | 146 | 253 | 104 |
Mean age, y (SD) | 60.3 (8.5) | 60.9 (7.8) | 62.1 (8.5) | 62.0 (7.8) | 61.4 (7.2) |
Caucasian, % | 86.8 | 81.0 | 90.4 | 95.3 | 96.2 |
First-degree family history of prostate cancer, % | 11.7 | 10.0 | 11.0 | 13.0 | 10.6 |
College or graduate degree, % | 60.3 | 56.0 | 61.0 | 62.5 | 46.2 |
Mean BMI, kg/m2 (SD) | 27.6 (5.2) | 28.2 (4.6) | 27.2 (4.1) | 27.6 (4.1) | 27.8 (4.5) |
Never smoker, % | 62.3 | 56.0 | 50.0 | 36.4 | 17.3 |
Aspirin use*, % | 47.9 | 51.0 | 52.1 | 53.0 | 60.6 |
Non-aspirin NSAID use*, % | 21.0 | 17.0 | 17.8 | 21.3 | 21.4 |
Diabetes mellitus, % | 9.7 | 10.0 | 9.6 | 12.6 | 9.6 |
History of PSA testing†, % | 55.3 | 51.0 | 67.1 | 61.7 | 57.7 |
≥1 cup of tea per day, % | 28.9 | 8.1 | 22.6 | 15.8 | 3.8 |
Abbreviations: SD, standard deviation; NSAID, non-steroidal anti-inflammatory drug; PSA, prostate-specific antigen.
Use at least once a week for 3 months or longer.
PSA testing within the 5-year period before reference date.